KVUE Stock: Kenvue Inc. Stock Price, Analysis & Insights

Get live kvue stock price $20.78, comprehensive Kenvue Inc. stock analysis, charts, news, and expert forecast. Real-time kvue stock data and investment insights.

20.78

0.34%Today

KVUE • Kenvue Inc. • New York Stock Exchange • Consumer Defensive

Market Cap

39.88B

Volume

11.61M

52W High

25.17

52W Low

19.75

Company Overview

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

Contact Information

Website: https://www.kenvue.com
Address: 199 Grandview Road
Country: US

Investment Analysis & Insights

Key Investment Highlights

Market Position: Consumer Defensive leader with 39.88B market capitalization
Trading Volume: 11.61M shares traded today
Price Range: 52-week range of $19.75 - $25.17
Exchange: Listed on New York Stock Exchange

Financial Metrics

P/E Ratio:27.71

EPS:$0.75

Beta:0.79

Avg Volume:18.21M

Market Analysis for Kenvue Inc.

Kenvue Inc. (KVUE) operates in the Household & Personal Products industry within the Consumer Defensive sector. With a current market capitalization of 39.88B, the company represents a significant player in its market. The stock is currently trading at $20.78 with a positivedaily change of 0.34%.

The company's 22000 employee base and presence on the New York Stock Exchangeexchange position it as a Consumer Defensive sector leader. Investors should consider the stock's P/E ratio of 27.71, beta of 0.79, and 52-week price range from $19.75 to $25.17when evaluating investment opportunities.